<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Pulmonary vein isolation with catheter ablation is an effective treatment in patients with symptomatic <z:hpo ids='HP_0005110'>atrial fibrillation</z:hpo> refractory or intolerant to antiarrhythmic medications </plain></SENT>
<SENT sid="1" pm="."><plain>The cryoballoon catheter was recently approved for this procedure </plain></SENT>
<SENT sid="2" pm="."><plain>In this paper, the basics of cryothermal energy ablation are reviewed including its ability of creating homogenous lesion formation, minimal destruction to surrounding vasculature, preserved tissue integrity, and lower risk of <z:e sem="disease" ids="C0302148,C0087086" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">thrombus</z:e> formation </plain></SENT>
<SENT sid="3" pm="."><plain>Also summarized here are the publications describing the clinical experience with the cryoballoon catheter ablation in both paroxysmal and persistent <z:hpo ids='HP_0005110'>atrial fibrillation</z:hpo>, its safety and efficacy, and discussions on the technical aspect of the cryoballoon ablation procedure </plain></SENT>
</text></document>